Correlation Between 4D Molecular and Aldeyra

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Aldeyra, you can compare the effects of market volatilities on 4D Molecular and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Aldeyra.

Diversification Opportunities for 4D Molecular and Aldeyra

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between FDMT and Aldeyra is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of 4D Molecular i.e., 4D Molecular and Aldeyra go up and down completely randomly.

Pair Corralation between 4D Molecular and Aldeyra

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Aldeyra. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 1.02 times less risky than Aldeyra. The stock trades about -0.01 of its potential returns per unit of risk. The Aldeyra is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  643.00  in Aldeyra on September 1, 2024 and sell it today you would lose (153.00) from holding Aldeyra or give up 23.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Aldeyra

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Aldeyra 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

4D Molecular and Aldeyra Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Aldeyra

The main advantage of trading using opposite 4D Molecular and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.
The idea behind 4D Molecular Therapeutics and Aldeyra pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments